Get the Stockscreener App
0.73
2.96%
0.021
After Hours:
.73
Nanovibronix Inc stock is traded at $0.73, with a volume of 42,033.
It is up +2.96% in the last 24 hours and up +33.70% over the past month.
NanoVibronix Inc manufactures noninvasive biological response-activating devices that target biofilm prevention, pain therapy, and wound healing and can be administered at home, without the assistance of medical professionals. Its primary products are UroShield; PainShield; and WoundShield. Each of its UroShield, PainShield, and WoundShield products employs a small, disposable transducer that transmits low-frequency, low-intensity ultrasound acoustic waves that seek to repair and regenerate tissue, musculoskeletal and vascular structures, and decrease biofilm formation on urinary catheters and associated urinary tract infections. The company derives revenues from selling its products directly to patients as well as through distributor agreements.
See More
Previous Close:
$0.709
Open:
$0.7303
24h Volume:
42,033
Relative Volume:
0.26
Market Cap:
$2.66M
Revenue:
$2.28M
Net Income/Loss:
$-3.71M
P/E Ratio:
-0.2173
EPS:
-3.36
Net Cash Flow:
$-3.60M
1W Performance:
+19.67%
1M Performance:
+33.70%
6M Performance:
-5.93%
1Y Performance:
-46.72%
1-Day Range:
$0.7108
$0.7494
1-Week Range:
$0.61
$0.7494
52-Week Range:
$0.4575
$1.52
Nanovibronix Inc Stock (NAOV) Company Profile
Name
Nanovibronix Inc
Sector
Industry
Phone
(914) 233-3004
Address
969 PRUITT AVE,, TYLER
Compare NAOV with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NAOV
Nanovibronix Inc
|
0.73 | 2.66M | 2.28M | -3.71M | -3.60M | -3.36 |
|
ABT
Abbott Laboratories
|
118.95 | 208.18B | 41.22B | 5.77B | 6.49B | 2.94 |
|
SYK
Stryker Corp
|
388.14 | 148.70B | 21.97B | 3.59B | 3.21B | 6.74 |
|
BSX
Boston Scientific Corp
|
90.75 | 133.32B | 15.91B | 1.79B | 1.89B | 0.82 |
|
MDT
Medtronic Plc
|
86.27 | 111.27B | 33.00B | 4.29B | 5.50B | 2.71 |
|
EW
Edwards Lifesciences Corp
|
72.07 | 42.66B | 6.60B | 4.16B | 490.10M | 2.34 |
Nanovibronix Inc Stock (NAOV) Latest News
NanoVibronix Faces Potential Delisting from Nasdaq Due to Non-Compliance - Defense World
NanoVibronix faces potential Nasdaq delisting - Investing.com
NanoVibronix faces potential Nasdaq delisting By Investing.com - Investing.com UK
NanoVibronix Third Quarter 2024 Earnings: US$0.36 loss per share (vs US$0.42 loss in 3Q 2023) - Yahoo Finance
Armistice Capital, LLC Expands Stake in NanoVibronix Inc - GuruFocus.com
NanoVibronix Inc (NAOV) Quarterly 10-Q Report - Quartzy
NanoVibronix expands global reach, eyes new markets By Investing.com - Investing.com South Africa
NanoVibronix expands global reach, eyes new markets - Investing.com
NanoVibronix Expands Global Reach with NHS Approval, South African Distribution Deal | NAOV Stock News - StockTitan
A look into NanoVibronix Inc (NAOV)’s deeper side - SETE News
Ratios in Focus: Analyzing NanoVibronix Inc (NAOV)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
NanoVibronix Inc (NAOV) Stock: A Year of Highs and Lows in the Market - The InvestChronicle
NanoVibronix Forges Potential New Distribution Deal - MPO-mag
NanoVibronix Takes Next Step to Partner with Specialist Urology Company to Expand Sales of UroShield in Germany - StockTitan
NanoVibronix stock hits 52-week low at $0.52 - Investing.com India
NanoVibronix stock hits 52-week low at $0.52 By Investing.com - Investing.com Canada
NanoVibronix extends CEO and CFO contracts with new terms - Investing.com India
NanoVibronix Secures Leadership with New Executive Agreements - TipRanks
NanoVibronix explores UroShield distribution in Israel By Investing.com - Investing.com Australia
NanoVibronix explores UroShield distribution in Israel - Investing.com
NAOVNanoVibronix, Inc. Latest Stock News & Market Updates - StockTitan
NanoVibronix Signs Letter of Intent with Potential New Distributor - StockTitan
Novo Nordisk and NanoVation to develop genetic medicines in partnership worth $600m - PMLiVE
Audit raises transparency concerns in IPO utilisation - The Business Post
UBC’s NanoVation Therapeutics inks US$600 million deal with Novo Nordisk - BCBusiness
Novo Nordisk and NanoVation Inked $600M+ Genetic Medicine Deal - Inside Precision Medicine
NanoVation partners with Novo Nordisk to develop genetic medicines - World Pharmaceutical Frontiers
Vancouver biotech inks $800M partnership with Novo Nordisk - Business in Vancouver
NanoVation inks genetic medicines deal with Novo Nordisk - The Pharma Letter
Novo Nordisk bets $600M biobucks on NanoVation's ability to take genetic medicines beyond the liver - Fierce Biotech
NanoVibronix (NASDAQ:NAOV) Stock Price Passes Below 50 Day Moving Average of $0.66 - Defense World
NanoVibronix (NASDAQ:NAOV) Stock Crosses Below 50-Day Moving Average of $0.70 - Defense World
NanoVibronix (STU:56R0) 5-Day RSI : 39.10 (As of Aug. 22, 2024) - GuruFocus.com
NanoVibronix (STU:56R0) Momentum Rank : 4 (As of Aug. 22, 2024) - GuruFocus.com
NanoVibronix (STU:56R0) Float Percentage Of Total Shares Ou - GuruFocus.com
NanoVibronix (STU:56R0) PE Ratio without NRI : At Loss (As of Aug. 22, 2024) - GuruFocus.com
NanoVibronix Highlights Second Quarter Revenue Growth and Narrowing of Loss from Operations in Letter to Stockholders - StockTitan
NAOV (NanoVibronix) Debt-to-Revenue : 0.03 (As of Mar. 2024) - GuruFocus.com
NAOV (NanoVibronix) EPS (Basic) : $-1.69 (TTM As of Mar. 2024) - GuruFocus.com
NanoVibronix Second Quarter 2024 Earnings: US$0.25 loss per share (vs US$0.65 loss in 2Q 2023) - Yahoo Finance
NanoVibronix (NASDAQ:NAOV) Stock Price Crosses Below 50 Day Moving Average of $0.72 - Defense World
NanoVibronix (STU:56R0) Short-Term Capital Lease Obligation : €0.04 Mil (As of Jun. 2024) - GuruFocus.com
NanoVibronix (NASDAQ:NAOV) Stock Passes Below Fifty Day Moving Average of $0.76 - Defense World
NanoVibronix stock hits 52-week low at $0.58 amid market challenges - Investing.com
NanoVibronix Inc (NAOV) Stock: Navigating Market Highs and Lows in 52 Weeks - The InvestChronicle
Financial Metrics Check: NanoVibronix Inc (NAOV)’s Ratios for Trailing Twelve Months - The Dwinnex
Short Interest in NanoVibronix, Inc. (NASDAQ:NAOV) Increases By 57.2% - Defense World
NanoVibronix (NASDAQ:NAOV) Share Price Crosses Below Fifty Day Moving Average of $0.76 - Defense World
Nanovibronix Inc (NAOV-Q) QuotePress Release - The Globe and Mail
NanoVibronix Announces Reverse Stock Split - Quantisnow
Nanovibronix Inc Stock (NAOV) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):